Related Articles
IDH mutations occur frequently in Chinese glioma patients and predict longer survival but not response to concomitant chemoradiotherapy in anaplastic gliomas
Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancers
IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells
Ten‑Eleven Translocation‑2 gene mutations: A potential new molecular marker in malignant gliomas (Review)
IDH1 mutation of gliomas with long-term survival analysis